Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-09

Clinical Trial Update: Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy [NA]

View source ↗

Summary

A clinical trial evaluating whether combining selective serotonin reuptake inhibitors (SSRIs) with phosphodiesterase-5 inhibitors offers benefits over monothera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phosphodiesterase-5 inhibitor (PDE-5i)
  • Selective serotonin reuptake inhibitor (SSRI)

Snippet

Sponsor: South Valley University | Conditions: Premature Ejaculation | NA | Status: NOT_YET_RECRUITING